Lemonade Analyst Ratings
Lemonade Analyst Ratings
Lemonade 分析師評級
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/11/2023 | -22.18% | Morgan Stanley | $15 → $10 | Maintains | Underweight |
| 09/28/2023 | -29.96% | BMO Capital | $8 → $9 | Maintains | Underperform |
| 08/04/2023 | 32.3% | Piper Sandler | $18 → $17 | Maintains | Neutral |
| 08/03/2023 | 16.73% | Morgan Stanley | $14 → $15 | Maintains | Underweight |
| 07/12/2023 | 211.29% | JMP Securities | → $40 | Reiterates | Market Outperform → Market Outperform |
| 06/20/2023 | 8.95% | Morgan Stanley | → $14 | Initiates Coverage On | → Underweight |
| 05/09/2023 | 32.3% | Barclays | $16 → $17 | Maintains | Equal-Weight |
| 05/05/2023 | 40.08% | Piper Sandler | → $18 | Reiterates | → Neutral |
| 05/04/2023 | -6.61% | B of A Securities | $14 → $12 | Maintains | Underperform |
| 05/04/2023 | 211.29% | JMP Securities | → $40 | Reiterates | → Market Outperform |
| 04/18/2023 | 211.29% | JMP Securities | → $40 | Reiterates | → Market Outperform |
| 04/10/2023 | -10.51% | Jefferies | $13 → $11.5 | Maintains | Underperform |
| 02/24/2023 | 24.51% | Barclays | $18 → $16 | Maintains | Equal-Weight |
| 02/24/2023 | 40.08% | Piper Sandler | $19 → $18 | Maintains | Neutral |
| 01/20/2023 | -22.18% | BMO Capital | → $10 | Initiates Coverage On | → Underperform |
| 01/18/2023 | 47.86% | Piper Sandler | $20 → $19 | Maintains | Neutral |
| 11/17/2022 | 86.77% | Keefe, Bruyette & Woods | → $24 | Initiates Coverage On | → Market Perform |
| 11/10/2022 | 40.08% | Barclays | $28 → $18 | Maintains | Equal-Weight |
| 11/10/2022 | 55.64% | Piper Sandler | $25 → $20 | Maintains | Neutral |
| 08/10/2022 | 117.9% | Barclays | $20 → $28 | Maintains | Equal-Weight |
| 08/10/2022 | 94.55% | Piper Sandler | $20 → $25 | Maintains | Neutral |
| 07/18/2022 | 55.64% | Piper Sandler | $24 → $20 | Downgrades | Overweight → Neutral |
| 05/13/2022 | 55.64% | Barclays | $22 → $20 | Maintains | Equal-Weight |
| 05/11/2022 | 133.46% | Oppenheimer | $45 → $30 | Maintains | Outperform |
| 05/11/2022 | 211.29% | JMP Securities | $95 → $40 | Maintains | Market Outperform |
| 05/11/2022 | 86.77% | Piper Sandler | $32 → $24 | Maintains | Overweight |
| 03/04/2022 | 117.9% | Morgan Stanley | $74 → $28 | Maintains | Equal-Weight |
| 02/25/2022 | 250.2% | Oppenheimer | $85 → $45 | Maintains | Outperform |
| 02/25/2022 | 149.03% | Piper Sandler | $54 → $32 | Maintains | Overweight |
| 01/13/2022 | 320.24% | Piper Sandler | $84 → $54 | Maintains | Overweight |
| 01/06/2022 | 234.63% | Barclays | $62 → $43 | Maintains | Equal-Weight |
| 11/19/2021 | 281.33% | Jefferies | → $49 | Initiates Coverage On | → Underperform |
| 11/10/2021 | 639.31% | JMP Securities | $130 → $95 | Maintains | Market Outperform |
| 11/10/2021 | 561.48% | Oppenheimer | $95 → $85 | Maintains | Outperform |
| 11/10/2021 | 382.49% | Barclays | $68 → $62 | Maintains | Equal-Weight |
| 10/19/2021 | 429.19% | Barclays | $80 → $68 | Maintains | Equal-Weight |
| 10/15/2021 | 475.88% | Morgan Stanley | $90 → $74 | Maintains | Equal-Weight |
| 08/17/2021 | 312.45% | Wolfe Research | → $53 | Initiates Coverage On | → Underperform |
| 08/06/2021 | 639.31% | Oppenheimer | $85 → $95 | Maintains | Outperform |
| 08/06/2021 | 662.65% | Piper Sandler | $103 → $98 | Maintains | Overweight |
| 05/13/2021 | 452.53% | Barclays | $101 → $71 | Maintains | Equal-Weight |
| 03/09/2021 | 125.68% | B of A Securities | → $29 | Initiates Coverage On | → Underperform |
| 03/08/2021 | 756.04% | Oppenheimer | → $110 | Upgrades | Perform → Outperform |
| 03/03/2021 | 911.68% | JMP Securities | $105 → $130 | Maintains | Outperform |
| 01/21/2021 | 1168.49% | Piper Sandler | $105 → $163 | Maintains | Overweight |
| 01/12/2021 | 600.39% | Morgan Stanley | $70 → $90 | Maintains | Equal-Weight |
| 12/16/2020 | 717.13% | Piper Sandler | $71 → $105 | Maintains | Overweight |
| 11/12/2020 | 452.53% | Piper Sandler | $63 → $71 | Maintains | Overweight |
| 11/02/2020 | 390.28% | Piper Sandler | → $63 | Initiates Coverage On | → Overweight |
| 10/15/2020 | 335.8% | Credit Suisse | → $56 | Initiates Coverage On | → Underperform |
| 08/14/2020 | 444.75% | Morgan Stanley | $91 → $70 | Maintains | Equal-Weight |
| 07/27/2020 | 242.42% | Goldman Sachs | → $44 | Initiates Coverage On | → Sell |
| 07/27/2020 | 608.18% | Morgan Stanley | → $91 | Initiates Coverage On | → Equal-Weight |
| 07/27/2020 | 545.92% | Barclays | → $83 | Initiates Coverage On | → Equal-Weight |
| 07/27/2020 | 717.13% | JMP Securities | → $105 | Initiates Coverage On | → Market Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年10月11日 | -22.18% | 摩根士丹利 | $15→$10 | 維護 | 體重不足 |
| 09/28/2023 | -29.96% | 蒙特利爾銀行資本 | $8→$9 | 維護 | 表現不佳 |
| 08/04/2023 | 32.3% | 派珀·桑德勒 | $18→$17 | 維護 | 中性 |
| 08/03/2023 | 16.73% | 摩根士丹利 | $14→$15 | 維護 | 體重不足 |
| 07/12/2023 | 211.29% | JMP證券 | →$40 | 重申 | 市場表現優於→市場表現 |
| 06/20/2023 | 8.95% | 摩根士丹利 | →$14 | 開始承保 | →減持 |
| 05/09/2023 | 32.3% | 巴克萊 | $16→$17 | 維護 | 等重 |
| 05/05/2023 | 40.08% | 派珀·桑德勒 | →$18 | 重申 | →中性 |
| 05/04/2023 | -6.61% | B of A證券 | $14→$12 | 維護 | 表現不佳 |
| 05/04/2023 | 211.29% | JMP證券 | →$40 | 重申 | →市場跑贏大盤 |
| 04/18/2023 | 211.29% | JMP證券 | →$40 | 重申 | →市場跑贏大盤 |
| 04/10/2023 | -10.51% | 傑富瑞 | $13→$11.5 | 維護 | 表現不佳 |
| 02/24/2023 | 24.51% | 巴克萊 | $18→$16 | 維護 | 等重 |
| 02/24/2023 | 40.08% | 派珀·桑德勒 | $19→$18 | 維護 | 中性 |
| 01/20/2023 | -22.18% | 蒙特利爾銀行資本 | →$10 | 開始承保 | →表現不佳 |
| 01/18/2023 | 47.86% | 派珀·桑德勒 | $20→$19 | 維護 | 中性 |
| 2022年11月17日 | 86.77% | Keefe，Bruyette&Wood | →$24 | 開始承保 | →市場表現 |
| 2022年11月10日 | 40.08% | 巴克萊 | $28→$18 | 維護 | 等重 |
| 2022年11月10日 | 55.64% | 派珀·桑德勒 | $25→$20 | 維護 | 中性 |
| 2022年08月10日 | 117.9% | 巴克萊 | $20→$28 | 維護 | 等重 |
| 2022年08月10日 | 94.55% | 派珀·桑德勒 | $20→$25 | 維護 | 中性 |
| 07/18/2022 | 55.64% | 派珀·桑德勒 | $24→$20 | 評級下調 | 超重→中性 |
| 2022年05月13日 | 55.64% | 巴克萊 | $22→$20 | 維護 | 等重 |
| 2022年05月11日 | 133.46% | 奧本海默 | $45→$30 | 維護 | 跑贏大盤 |
| 2022年05月11日 | 211.29% | JMP證券 | $95→$40 | 維護 | 市場表現強於大盤 |
| 2022年05月11日 | 86.77% | 派珀·桑德勒 | $32→$24 | 維護 | 超重 |
| 03/04/2022 | 117.9% | 摩根士丹利 | $74→$28 | 維護 | 等重 |
| 02/25/2022 | 250.2% | 奧本海默 | $85→$45 | 維護 | 跑贏大盤 |
| 02/25/2022 | 149.03% | 派珀·桑德勒 | $54→$32 | 維護 | 超重 |
| 2022年01月13日 | 320.24% | 派珀·桑德勒 | $84→$54 | 維護 | 超重 |
| 01/06/2022 | 234.63% | 巴克萊 | $62→$43 | 維護 | 等重 |
| 2021年11月19日 | 281.33% | 傑富瑞 | →$49 | 開始承保 | →表現不佳 |
| 2021年11月10日 | 639.31% | JMP證券 | $130→$95 | 維護 | 市場表現強於大盤 |
| 2021年11月10日 | 561.48% | 奧本海默 | $95→$85 | 維護 | 跑贏大盤 |
| 2021年11月10日 | 382.49% | 巴克萊 | $68→$62 | 維護 | 等重 |
| 10/19/2021 | 429.19% | 巴克萊 | $80→$68 | 維護 | 等重 |
| 2021年10月15日 | 475.88% | 摩根士丹利 | $90→$74 | 維護 | 等重 |
| 2021/08/17 | 312.45% | 沃爾夫研究 | →$53 | 開始承保 | →表現不佳 |
| 08/06/2021 | 639.31% | 奧本海默 | $85→$95 | 維護 | 跑贏大盤 |
| 08/06/2021 | 662.65% | 派珀·桑德勒 | $103→$98 | 維護 | 超重 |
| 2021/05/13 | 452.53% | 巴克萊 | $101→$71 | 維護 | 等重 |
| 03/09/2021 | 125.68% | B of A證券 | →$29 | 開始承保 | →表現不佳 |
| 03/08/2021 | 756.04% | 奧本海默 | →$110 | 升級 | →表現強於大盤 |
| 03/03/2021 | 911.68% | JMP證券 | $105→$130 | 維護 | 跑贏大盤 |
| 2021/01/21 | 1168.49% | 派珀·桑德勒 | $105→$163 | 維護 | 超重 |
| 2021/12/01 | 600.39% | 摩根士丹利 | $70→$90 | 維護 | 等重 |
| 12/16/2020 | 717.13% | 派珀·桑德勒 | $71→$105 | 維護 | 超重 |
| 2020年11月12日 | 452.53% | 派珀·桑德勒 | $63→$71 | 維護 | 超重 |
| 11/02/2020 | 390.28% | 派珀·桑德勒 | →$63 | 開始承保 | →超重 |
| 10/15/2020 | 335.8% | 瑞士信貸 | →$56 | 開始承保 | →表現不佳 |
| 2020/08/14 | 444.75% | 摩根士丹利 | $91→$70 | 維護 | 等重 |
| 07/27/2020 | 242.42% | 高盛 | →$44 | 開始承保 | →銷售 |
| 07/27/2020 | 608.18% | 摩根士丹利 | →$91 | 開始承保 | →等重 |
| 07/27/2020 | 545.92% | 巴克萊 | →$83 | 開始承保 | →等重 |
| 07/27/2020 | 717.13% | JMP證券 | →$105 | 開始承保 | →市場跑贏大盤 |
What is the target price for Lemonade (LMND)?
Lemonade(Lemonade)的目標價是多少？
The latest price target for Lemonade (NYSE: LMND) was reported by Morgan Stanley on October 11, 2023. The analyst firm set a price target for $10.00 expecting LMND to fall to within 12 months (a possible -22.18% downside). 19 analyst firms have reported ratings in the last year.
檸檬水(紐約證券交易所代碼：LMND)的最新目標價是由摩根士丹利於2023年10月11日報道的。這家分析公司將目標價定為10.00美元，預計LMND將在12個月內降至(可能下跌22.18%)。去年有19家分析公司公佈了評級。
What is the most recent analyst rating for Lemonade (LMND)?
Lemonade(Lemonade)的最新分析師評級是多少？
The latest analyst rating for Lemonade (NYSE: LMND) was provided by Morgan Stanley, and Lemonade maintained their underweight rating.
Lemonade(紐約證券交易所股票代碼：LMND)的最新分析師評級由摩根士丹利提供，Lemonade維持其減持評級。
When is the next analyst rating going to be posted or updated for Lemonade (LMND)?
Lemonade(Lemonade)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lemonade, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lemonade was filed on October 11, 2023 so you should expect the next rating to be made available sometime around October 11, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Lemonade的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Lemonade的上一次評級是在2023年10月11日提交的，所以你應該預計下一次評級將在2024年10月11日左右公佈。
Is the Analyst Rating Lemonade (LMND) correct?
分析師對Lemonade(LMND)的評級正確嗎？
While ratings are subjective and will change, the latest Lemonade (LMND) rating was a maintained with a price target of $15.00 to $10.00. The current price Lemonade (LMND) is trading at is $12.85, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Lemonade(LMND)評級維持不變，目標價在15.00美元至10.00美元之間。Lemonade目前的交易價格為12.85美元，超出了分析師的預測區間。